-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Novel Technologies in Red Blood Cell Quality Assessment

Symposia: Scientific Workshop on Challenges and Novel Technologies in Red Blood Cell Quality Assessment Program: Scientific Workshops
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Artificial intelligence (AI), Translational Research, Assays, Bioinformatics, Blood banking, Metabolism, Emerging technologies, Technology and Procedures, Gene editing, Profiling, Human, Imaging, Machine learning, Molecular testing, Omics technologies
Friday, December 6, 2024: 3:30 PM-4:45 PM
Room 3 (San Diego Convention Center)
Moderator:
and O. Berk Usta, PhD, Massachusetts General Hospital
Disclosures:
Usta: Millipore Sigma: Consultancy; Abata Therapeutics: Other: Spouse is a current employee.
In this session, we will provide an overview of technological needs and a summary of new and emerging technologies for red blood cell quality assessment.

O. Berk Usta, PhD

Massachusetts General Hospital, Boston, MA

Travis Nemkov, PhD

University of Colorado Anschutz Medical Campus, Aurora, CO

Amin T. Turki, MD

Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany

Allan Doctor, MD

University of Maryland, Baltimore, MD